aluates Reports

$ 0.0

Automative

Global OTC Anti-Infective Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-32E9959

Global OTC Anti Infective Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global OTC Anti-Infective Drug Market Research Report 2025

Code: QYRE-Auto-32E9959

Report

July 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

GSK

TEVA

Johnson & Johnson

Novartis

Mylan NV

Sun Pharma

CR SANJIU

Cipla Ltd

Lingrui

OTC Anti-Infective Drug Market Size

The global market for OTC Anti-Infective Drug was valued at US$ 25270 million in the year 2024 and is projected to reach a revised size of US$ 43720 million by 2031, growing at a CAGR of 8.3% during the forecast period.

OTC Anti-Infective Drug Market

Anti-infectives are medicines that work to prevent or treat infections.

The Over-the-Counter (OTC) Anti-Infective Drug market has grown as a convenient option for consumers seeking self-treatment for minor infections. These drugs, available without a prescription, include topical ointments, creams, and oral medications for conditions like skin infections, cold sores, and vaginal infections. The market"s expansion is driven by the demand for accessible and cost-effective solutions to address common infections without the need for a doctor"s visit. As awareness of self-care and health empowerment increases, the OTC Anti-Infective Drug market continues to offer a range of effective options that enable individuals to manage mild infections quickly and conveniently.

This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Drug.

The OTC Anti-Infective Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Anti-Infective Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the OTC Anti-Infective Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of OTC Anti-Infective Drug Market Report

Report Metric	Details
Report Name	OTC Anti-Infective Drug Market
Accounted market size in year	US$ 25270 million
Forecasted market size in 2031	US$ 43720 million
CAGR	8.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antifungal Antibacterial Antiviral Antiseptics Other
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU, Cipla, Lingrui
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is OTC Anti-Infective Drug Market growing?

Ans: The OTC Anti-Infective Drug Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the OTC Anti-Infective Drug Market size in 2031?

Ans: The OTC Anti-Infective Drug Market size in 2031 will be US$ 43720 million.

Who are the main players in the OTC Anti-Infective Drug Market report?

Ans: The main players in the OTC Anti-Infective Drug Market are Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU, Cipla, Lingrui

What are the Application segmentation covered in the OTC Anti-Infective Drug Market report?

Ans: The Applications covered in the OTC Anti-Infective Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the OTC Anti-Infective Drug Market report?

Ans: The Types covered in the OTC Anti-Infective Drug Market report are Antifungal, Antibacterial, Antiviral, Antiseptics, Other

Recommended Reports

OTC Drug Markets

Anti-Infective Drugs

Infectious Disease Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antifungal

1.2.3 Antibacterial

1.2.4 Antiviral

1.2.5 Antiseptics

1.2.6 Other

1.3 Market by Application

1.3.1 Global OTC Anti-Infective Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global OTC Anti-Infective Drug Market Perspective (2020-2031)

2.2 Global OTC Anti-Infective Drug Growth Trends by Region

2.2.1 Global OTC Anti-Infective Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 OTC Anti-Infective Drug Historic Market Size by Region (2020-2025)

2.2.3 OTC Anti-Infective Drug Forecasted Market Size by Region (2026-2031)

2.3 OTC Anti-Infective Drug Market Dynamics

2.3.1 OTC Anti-Infective Drug Industry Trends

2.3.2 OTC Anti-Infective Drug Market Drivers

2.3.3 OTC Anti-Infective Drug Market Challenges

2.3.4 OTC Anti-Infective Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top OTC Anti-Infective Drug Players by Revenue

3.1.1 Global Top OTC Anti-Infective Drug Players by Revenue (2020-2025)

3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2020-2025)

3.2 Global OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by OTC Anti-Infective Drug Revenue

3.4 Global OTC Anti-Infective Drug Market Concentration Ratio

3.4.1 Global OTC Anti-Infective Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Drug Revenue in 2024

3.5 Global Key Players of OTC Anti-Infective Drug Head office and Area Served

3.6 Global Key Players of OTC Anti-Infective Drug, Product and Application

3.7 Global Key Players of OTC Anti-Infective Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 OTC Anti-Infective Drug Breakdown Data by Type

4.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2020-2025)

4.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2026-2031)

5 OTC Anti-Infective Drug Breakdown Data by Application

5.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2020-2025)

5.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America OTC Anti-Infective Drug Market Size (2020-2031)

6.2 North America OTC Anti-Infective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America OTC Anti-Infective Drug Market Size by Country (2020-2025)

6.4 North America OTC Anti-Infective Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe OTC Anti-Infective Drug Market Size (2020-2031)

7.2 Europe OTC Anti-Infective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe OTC Anti-Infective Drug Market Size by Country (2020-2025)

7.4 Europe OTC Anti-Infective Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific OTC Anti-Infective Drug Market Size (2020-2031)

8.2 Asia-Pacific OTC Anti-Infective Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America OTC Anti-Infective Drug Market Size (2020-2031)

9.2 Latin America OTC Anti-Infective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America OTC Anti-Infective Drug Market Size by Country (2020-2025)

9.4 Latin America OTC Anti-Infective Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa OTC Anti-Infective Drug Market Size (2020-2031)

10.2 Middle East & Africa OTC Anti-Infective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer OTC Anti-Infective Drug Introduction

11.1.4 Bayer Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK OTC Anti-Infective Drug Introduction

11.2.4 GSK Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.2.5 GSK Recent Development

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva OTC Anti-Infective Drug Introduction

11.3.4 Teva Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.3.5 Teva Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson OTC Anti-Infective Drug Introduction

11.4.4 Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 NOVARTIS

11.5.1 NOVARTIS Company Details

11.5.2 NOVARTIS Business Overview

11.5.3 NOVARTIS OTC Anti-Infective Drug Introduction

11.5.4 NOVARTIS Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.5.5 NOVARTIS Recent Development

11.6 MYLAN

11.6.1 MYLAN Company Details

11.6.2 MYLAN Business Overview

11.6.3 MYLAN OTC Anti-Infective Drug Introduction

11.6.4 MYLAN Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.6.5 MYLAN Recent Development

11.7 Sun Pharma

11.7.1 Sun Pharma Company Details

11.7.2 Sun Pharma Business Overview

11.7.3 Sun Pharma OTC Anti-Infective Drug Introduction

11.7.4 Sun Pharma Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.7.5 Sun Pharma Recent Development

11.8 CR SANJIU

11.8.1 CR SANJIU Company Details

11.8.2 CR SANJIU Business Overview

11.8.3 CR SANJIU OTC Anti-Infective Drug Introduction

11.8.4 CR SANJIU Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.8.5 CR SANJIU Recent Development

11.9 Cipla

11.9.1 Cipla Company Details

11.9.2 Cipla Business Overview

11.9.3 Cipla OTC Anti-Infective Drug Introduction

11.9.4 Cipla Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.9.5 Cipla Recent Development

11.10 Lingrui

11.10.1 Lingrui Company Details

11.10.2 Lingrui Business Overview

11.10.3 Lingrui OTC Anti-Infective Drug Introduction

11.10.4 Lingrui Revenue in OTC Anti-Infective Drug Business (2020-2025)

11.10.5 Lingrui Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

GSK

TEVA

Johnson & Johnson

Novartis

Mylan NV

Sun Pharma

CR SANJIU

Cipla Ltd

Lingrui

List of Tables

Table 1. Global OTC Anti-Infective Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antifungal

Table 3. Key Players of Antibacterial

Table 4. Key Players of Antiviral

Table 5. Key Players of Antiseptics

Table 6. Key Players of Other

Table 7. Global OTC Anti-Infective Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global OTC Anti-Infective Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global OTC Anti-Infective Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global OTC Anti-Infective Drug Market Share by Region (2020-2025)

Table 11. Global OTC Anti-Infective Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global OTC Anti-Infective Drug Market Share by Region (2026-2031)

Table 13. OTC Anti-Infective Drug Market Trends

Table 14. OTC Anti-Infective Drug Market Drivers

Table 15. OTC Anti-Infective Drug Market Challenges

Table 16. OTC Anti-Infective Drug Market Restraints

Table 17. Global OTC Anti-Infective Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global OTC Anti-Infective Drug Market Share by Players (2020-2025)

Table 19. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2024)

Table 20. Ranking of Global Top OTC Anti-Infective Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by OTC Anti-Infective Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of OTC Anti-Infective Drug, Headquarters and Area Served

Table 23. Global Key Players of OTC Anti-Infective Drug, Product and Application

Table 24. Global Key Players of OTC Anti-Infective Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global OTC Anti-Infective Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global OTC Anti-Infective Drug Revenue Market Share by Type (2020-2025)

Table 28. Global OTC Anti-Infective Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global OTC Anti-Infective Drug Revenue Market Share by Type (2026-2031)

Table 30. Global OTC Anti-Infective Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global OTC Anti-Infective Drug Revenue Market Share by Application (2020-2025)

Table 32. Global OTC Anti-Infective Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global OTC Anti-Infective Drug Revenue Market Share by Application (2026-2031)

Table 34. North America OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America OTC Anti-Infective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America OTC Anti-Infective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe OTC Anti-Infective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe OTC Anti-Infective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific OTC Anti-Infective Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America OTC Anti-Infective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America OTC Anti-Infective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Bayer Company Details

Table 50. Bayer Business Overview

Table 51. Bayer OTC Anti-Infective Drug Product

Table 52. Bayer Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 53. Bayer Recent Development

Table 54. GSK Company Details

Table 55. GSK Business Overview

Table 56. GSK OTC Anti-Infective Drug Product

Table 57. GSK Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 58. GSK Recent Development

Table 59. Teva Company Details

Table 60. Teva Business Overview

Table 61. Teva OTC Anti-Infective Drug Product

Table 62. Teva Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 63. Teva Recent Development

Table 64. Johnson & Johnson Company Details

Table 65. Johnson & Johnson Business Overview

Table 66. Johnson & Johnson OTC Anti-Infective Drug Product

Table 67. Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 68. Johnson & Johnson Recent Development

Table 69. NOVARTIS Company Details

Table 70. NOVARTIS Business Overview

Table 71. NOVARTIS OTC Anti-Infective Drug Product

Table 72. NOVARTIS Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 73. NOVARTIS Recent Development

Table 74. MYLAN Company Details

Table 75. MYLAN Business Overview

Table 76. MYLAN OTC Anti-Infective Drug Product

Table 77. MYLAN Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 78. MYLAN Recent Development

Table 79. Sun Pharma Company Details

Table 80. Sun Pharma Business Overview

Table 81. Sun Pharma OTC Anti-Infective Drug Product

Table 82. Sun Pharma Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 83. Sun Pharma Recent Development

Table 84. CR SANJIU Company Details

Table 85. CR SANJIU Business Overview

Table 86. CR SANJIU OTC Anti-Infective Drug Product

Table 87. CR SANJIU Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 88. CR SANJIU Recent Development

Table 89. Cipla Company Details

Table 90. Cipla Business Overview

Table 91. Cipla OTC Anti-Infective Drug Product

Table 92. Cipla Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 93. Cipla Recent Development

Table 94. Lingrui Company Details

Table 95. Lingrui Business Overview

Table 96. Lingrui OTC Anti-Infective Drug Product

Table 97. Lingrui Revenue in OTC Anti-Infective Drug Business (2020-2025) & (US$ Million)

Table 98. Lingrui Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. OTC Anti-Infective Drug Picture

Figure 2. Global OTC Anti-Infective Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global OTC Anti-Infective Drug Market Share by Type: 2024 VS 2031

Figure 4. Antifungal Features

Figure 5. Antibacterial Features

Figure 6. Antiviral Features

Figure 7. Antiseptics Features

Figure 8. Other Features

Figure 9. Global OTC Anti-Infective Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global OTC Anti-Infective Drug Market Share by Application: 2024 VS 2031

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. OTC Anti-Infective Drug Report Years Considered

Figure 15. Global OTC Anti-Infective Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global OTC Anti-Infective Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global OTC Anti-Infective Drug Market Share by Region: 2024 VS 2031

Figure 18. Global OTC Anti-Infective Drug Market Share by Players in 2024

Figure 19. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by OTC Anti-Infective Drug Revenue in 2024

Figure 21. North America OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America OTC Anti-Infective Drug Market Share by Country (2020-2031)

Figure 23. United States OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe OTC Anti-Infective Drug Market Share by Country (2020-2031)

Figure 27. Germany OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific OTC Anti-Infective Drug Market Share by Region (2020-2031)

Figure 35. China OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America OTC Anti-Infective Drug Market Share by Country (2020-2031)

Figure 43. Mexico OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa OTC Anti-Infective Drug Market Share by Country (2020-2031)

Figure 47. Turkey OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE OTC Anti-Infective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Bayer Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 51. GSK Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 52. Teva Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 53. Johnson & Johnson Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 54. NOVARTIS Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 55. MYLAN Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 56. Sun Pharma Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 57. CR SANJIU Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 58. Cipla Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 59. Lingrui Revenue Growth Rate in OTC Anti-Infective Drug Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global OTC Anti Infective Products Market Research Report 2025

Global Anti infectives Medicine Market Research Report 2025

Anti Infective Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Anti Infective Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Infective Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Anti Infective Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pets Anti Infective Medicine Market Insights Forecast to 2030

Global Anti Infective Medications Market Research Report 2024

Global Anti Infective Ophthalmic Market Insights Forecast to 2030

Global Ophthalmic Anti infective Drug Market Research Report 2025

Global Anti Infective Therapy Market Research Report 2024

Systemic Anti Infectives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Anti infective Preparations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Burn Treatment Anti Infectives Products Market Insights Forecast to 2030

Global Animal Anti Infective Medicine Market Insights Forecast to 2030

Global Anti infective Ophthalmic Preparation Market Research Report 2024

Global Livestock Anti Infective Medicine Market Insights Forecast to 2030

Global Anti infective Drugs for Animals Market Research Report 2024

Global Animal Anti infectives Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions